TW201713340A - 經皮傳遞系統 - Google Patents

經皮傳遞系統 Download PDF

Info

Publication number
TW201713340A
TW201713340A TW105124084A TW105124084A TW201713340A TW 201713340 A TW201713340 A TW 201713340A TW 105124084 A TW105124084 A TW 105124084A TW 105124084 A TW105124084 A TW 105124084A TW 201713340 A TW201713340 A TW 201713340A
Authority
TW
Taiwan
Prior art keywords
hours
dihydroetorphine
plasma concentration
less
patch
Prior art date
Application number
TW105124084A
Other languages
English (en)
Chinese (zh)
Inventor
史帝夫 懷特洛克
黛柏拉 菲利斯 哈汀
海倫 強森
凱文 史密斯
吉兒 暮汀
Original Assignee
歐陸斯迪公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 歐陸斯迪公司 filed Critical 歐陸斯迪公司
Publication of TW201713340A publication Critical patent/TW201713340A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW105124084A 2015-07-30 2016-07-29 經皮傳遞系統 TW201713340A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1513441.4A GB201513441D0 (en) 2015-07-30 2015-07-30 Transdermal delivery system

Publications (1)

Publication Number Publication Date
TW201713340A true TW201713340A (zh) 2017-04-16

Family

ID=54062902

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105124084A TW201713340A (zh) 2015-07-30 2016-07-29 經皮傳遞系統

Country Status (16)

Country Link
US (1) US20180221299A1 (enExample)
EP (1) EP3328431A1 (enExample)
JP (1) JP2018528175A (enExample)
KR (1) KR20180035859A (enExample)
CN (1) CN108025077A (enExample)
AR (1) AR105533A1 (enExample)
AU (1) AU2016298761A1 (enExample)
BR (1) BR112018001615A2 (enExample)
CA (1) CA2994103A1 (enExample)
GB (1) GB201513441D0 (enExample)
IL (1) IL256995A (enExample)
MA (1) MA42521A (enExample)
MX (1) MX2018001318A (enExample)
SG (1) SG10201913254RA (enExample)
TW (1) TW201713340A (enExample)
WO (1) WO2017017452A1 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10231248A (ja) * 1997-02-19 1998-09-02 T T S Gijutsu Kenkyusho:Kk ジヒドロエトルフィン含有経皮吸収型製剤
US6716449B2 (en) * 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
CL2004000927A1 (es) * 2003-04-30 2005-01-28 Purdue Pharma Lp Forma de dosificacion transdermica que comprende un agente activo, una superficie proxima y una superficie distal.
TWI541246B (zh) * 2008-12-08 2016-07-11 歐陸斯迪公司 二氫羥戊甲嗎啡

Also Published As

Publication number Publication date
EP3328431A1 (en) 2018-06-06
CN108025077A (zh) 2018-05-11
US20180221299A1 (en) 2018-08-09
AR105533A1 (es) 2017-10-11
BR112018001615A2 (pt) 2018-09-18
SG10201913254RA (en) 2020-03-30
MA42521A (fr) 2018-06-06
GB201513441D0 (en) 2015-09-16
KR20180035859A (ko) 2018-04-06
JP2018528175A (ja) 2018-09-27
WO2017017452A1 (en) 2017-02-02
MX2018001318A (es) 2018-08-15
IL256995A (en) 2018-03-29
AU2016298761A1 (en) 2018-02-15
CA2994103A1 (en) 2017-02-02

Similar Documents

Publication Publication Date Title
KR101159828B1 (ko) 활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형
ES2592277T3 (es) Formulaciones transdérmicas disuasorias del abuso de agonistas y agonistas-antagonistas opiáceos
US10729686B2 (en) Pharmaceutical compositions
CA2679316C (en) Morphine composition for transdermal absorption, morphine composition storing unit and transdermal absorption preparation using the same
TWI764951B (zh) 用於處理疼痛之右美托咪啶經皮遞送裝置
CN100409847C (zh) 乌头属生物碱经皮给药系统
CN101146523B (zh) 透皮给药系统
TW201521796A (zh) 用於經皮傳遞三級胺藥物之組合物及方法
US20190328681A1 (en) Transdermal patch
JP6600658B2 (ja) 日に１回の取り替えによるフェンタニルの経皮投与
US20070248657A1 (en) Multi-compartment transdermal pain control device
TW201713340A (zh) 經皮傳遞系統
JP6512905B2 (ja) フェンタニル含有貼付剤
TW201707693A (zh) 經皮傳遞系統
TW202440102A (zh) 含多奈哌齊之經皮吸收製劑